Eton Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $821K, a 5.85% decline year-over-year.
  • Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.09M, a 23% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 25.6% decline from 2022.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.22M, a 24.8% increase from 2021.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.38M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.14M -$1.08M -25.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $4.22M +$837K +24.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $3.38M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2019 $1.89M +$38K +2.05% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-05
2018 $1.85M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.